Development of endothelial-targeted CD39 as a therapy for ischaemic stroke.
Lee NT, Savvidou I, Selan C, Calvello I, Vuong A, Wright DK, Brkljaca R, Willcox A, Chia JS, Wang X, Peter K, Robson SC, Medcalf RL, Nandurkar HH, Sashindranath M.
Lee NT, et al. Among authors: wang x.
J Thromb Haemost. 2024 May 14:S1538-7836(24)00281-2. doi: 10.1016/j.jtha.2024.04.023. Online ahead of print.
J Thromb Haemost. 2024.
PMID: 38754782